Can I use GLP-1 analogues if I have a history of depression or mental health conditions
Reviews in Endocrine & Metabolic Disorders, 23 (3), 521539
During the progression stage, hypoxia, hormones, growth factors, and lipid signaling repeatedly activate survival and growth pathways, such as those involving HIF-1/VEGF, JAK/STAT3, and AKT/mTOR, through ROS-mediated mechanisms to promote tumor cell proliferation, anti-apoptotic activity, and angiogenesis

CrossRef Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 20102023 Jialin Wu, Bonan Chen, Fuda Xie, Jiahui Hu, Mingyu Liang, Yang Lyu, Peiyao Yu, Tiejun Feng, Muyang Huang, Canbin Fang, Ka Fai To, Terry Cheuk-Fung Yip, Xingxin Wang, Wei Kang Hepatology International .2026;[Epub] CrossRef Development and Validation of a Deep Learningenabled Single Breath-hold Abbreviated MRI Protocol for Hepatocellular Carcinoma Diagnosis Yunfei Zhang, Zhijun Geng, Xianling Qian, Yuyao Xiao, Ruofan Sheng, Mengsu Zeng Radiology: Artificial Intelligence .2026;[Epub] CrossRef Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (20202025) Qi-Feng Chen, Song Chen, Xiongying Jiang, Jiongliang Wang, Ming Zhao Liver Cancer .2026